ClassID:

21647

A61K2300/00 - page 80 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#23701
20050249706
2005-11-10

Compositions and methods for tumor-targeted delivery of effector molecules

#23702
20050249704
2005-11-10

Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist

#23703
20050249702
2005-11-10

(1R,2S,5S)-N-[(1S)-3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide as inhibitor of hepatitis C virus NS3/NS4a serine protease

#23704
20050249700
2005-11-10

Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling

#23705
20050249699
2005-11-10

Immunodynamic complexes and methods for using and preparing such complexes

#23706
20050249698
2005-11-10

Synergistic effect of the osteogenic growth peptide and the granulocyte clony stimulating factor on haematogenesis

#23707
20050249693
2005-11-10

Composition for inhalation therapy and methods for use

#23708
20050249663
2005-11-10

Coadministration of transport protein with conjugated cobalamin to deliver agents

#23709
20050245617
2005-11-03

Methods and compositions for the treatment of CNS-related conditions

#23710
20050245612
2005-11-03

Pharmaceutical compositions for metabolic insufficiencies

#23711
20050245610
2005-11-03

Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease

#23712
20050245563
2005-11-03

Chk-1 inhibitors

#23713
20050245557
2005-11-03

Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain

#23714
20050245556
2005-11-03

Pharmaceutical preparation containing oxycodone and naloxone

#23715
20050245549
2005-11-03

Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer

#23716
20050245543
2005-11-03

Histamine-3 receptor antagonists

#23717
20050245541
2005-11-03

Methods for treating alcoholism

#23718
20050245539
2005-11-03

Pharmaceutical compositions for the treatment of sexual disorders II

#23719
20050245525
2005-11-03

Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1

#23720
20050245509
2005-11-03

Remedy for glaucoma comprising rho kinase inhibitor and prostaglandins

#23721
20050245506
2005-11-03

Treatment of congestive heart failure

#23722
20050245504
2005-11-03

Treatment of diseases with combinations of alpha 7 Nicotinic Acetylcholine Receptor agonists and other compounds

#23723
20050245502
2005-11-03

Treatments for viral infections

#23724
20050245499
2005-11-03

Heterocyclic protein kinase inhibitors and uses thereof

#23725
20050245494
2005-11-03

Methods to treat one or all of the defined etiologies of female sexual dysfunction

#23726
20050245493
2005-11-03

Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

#23727
20050245483
2005-11-03

Matrix for sustained, invariant and independent release of active compounds

#23728
20050245468
2005-11-03

Anthelmintic composition

#23729
20050245467
2005-11-03

Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract

#23730
20050245466
2005-11-03

Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy

#23731
20050245462
2005-11-03

Treatment of cancer with 2-deoxyglucose

#23732
20050245461
2005-11-03

Methods for treating alcoholism

#23733
20050245460
2005-11-03

Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders

#23734
20050245456
2005-11-03

Combination therapy to prevent and treat diarrhea induced by cancer treatment

#23735
20050245446
2005-11-03

Materials for the delivery of biologically-active material to cells

#23736
20050245444
2005-11-03

Method of using recombinant human antithrombin for neurocognitive disorders

#23737
20050245440
2005-11-03

Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2

#23738
20050245436
2005-11-03

Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis

#23739
20050244965
2005-11-03

Oligodendrocyte production from multipotent neural stem cells

#23740
20050244905
2005-11-03

Nitrated fibrinogen as a marker for coronary artery disease and rapid blood clot formation

#23741
20050244525
2005-11-03

Topical composition comprising feverfew

#23742
20050244524
2005-11-03

Blood sugar regulating product from soybean seeds

#23743
20050244523
2005-11-03

Topical anti-cancer compositions and methods of use thereof

#23744
20050244522
2005-11-03

Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents

#23745
20050244521
2005-11-03

Tobacco compositions

#23746
20050244520
2005-11-03

Topical menthol, or a related cooling compound, to induce lubrication

#23747
20050244519
2005-11-03

Bulking agent compositions

#23748
20050244517
2005-11-03

Combination of proton pump inhibitor and sleep aid

#23749
20050244515
2005-11-03

Anti-microbial agent and anti-microbial composition

#23750
20050244512
2005-11-03

Ophthalmic fluid and method of delivering same

#23751
20050244511
2005-11-03

Trace elements

#23752
20050244510
2005-11-03

Compositions for improving mental performance

#23753
20050244509
2005-11-03

Ophthalmic solutions

#23754
20050244508
2005-11-03

Anti-spasmodic comprising xenon

#23755
20050244474
2005-11-03

Steroid-containing sustained release intraocular implants and related methods

#23756
20050244468
2005-11-03

Sustained release intraocular implants and related methods

#23757
20050244466
2005-11-03

Photodynamic therapy in conjunction with intraocular implants

#23758
20050244451
2005-11-03

Method and device for reducing susceptibility to fractures in vertebral bodies

#23759
20050244433
2005-11-03

Treatment of papillomavirus infections

#23760
20050244423
2005-11-03

Methods for treating viral infection using IL-28 and IL-29 cysteine mutants

#23761
20050244417
2005-11-03

Apo-2 ligand-anti-Her-2 antibody synergism

#23762
20050244413
2005-11-03

Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents

#23763
20050244412
2005-11-03

Method and composition for regulating activity of regulatory T cells

#23764
20050244408
2005-11-03

Antibodies to insulin-like growth factor I receptor

#23765
20050244407
2005-11-03

Therapeutic synergy of anti-cancer compounds

#23766
20050244393
2005-11-03

Sealant or tissue generating product

#23767
20050244391
2005-11-03

Method to enhance fat content in the milk of a diary cow

#23768
20050244390
2005-11-03

COMPOSITIONS AND METHODS FOR INHIBITING PATHOGENIC GROWTH

#23769
20050244375
2005-11-03

Composition and method of cancer treatment

#23770
20050244369
2005-11-03

Dietary supplement

#23771
20050244363
2005-11-03

Hyaluronic acid based copolymers

#23772
20050244358
2005-11-03

Use of mixture of sodium hyaluronate and chondroitin sulfate for use in products and therapies for cosmetic surgery

#23773
20050244344
2005-11-03

Compositions for oral hygiene and method for using same

#23774
20050240021
2005-10-27

Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators

#23775
20050240012
2005-10-27

Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity

#23776
20050239904
2005-10-27

Polycosanols from Ericerus pela wax

#23777
20050239900
2005-10-27

Use of low molecular weight amino alcohols in ophthalmic compositions

#23778
20050239892
2005-10-27

Therapeutic avenathramide compounds

#23779
20050239891
2005-10-27

Use of citrulline within the framework of intestinal insufficiency

#23780
20050239890
2005-10-27

Methods for decreasing detrusor muscle overactivity

#23781
20050239887
2005-10-27

Pharmaceutical composition containing glimepiride and metformin hydrochloride

#23782
20050239876
2005-10-27

Tocopherol and tocotrienol aerosols

#23783
20050239872
2005-10-27

1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma

#23784
20050239867
2005-10-27

Methods of using and compositions comprising PDE4 modulators for the treatment and management of pulmonary hypertension

#23785
20050239857
2005-10-27

Novel imidazoles

#23786
20050239854
2005-10-27

Body weight gain inhibitors

#23787
20050239845
2005-10-27

Combination of proton pump inhibitor, buffering agent, and prokinetic agent

#23788
20050239778
2005-10-27

Novel medicament combinations for the treatment of respiratory diseases

#23789
20050239763
2005-10-27

Non-GMO metal amino acid chelates and non-GMO metal amino acid chelate-containing compositions

#23790
20050239762
2005-10-27

Estriol therapy for multiple sclerosis and other autoimmune diseases

#23791
20050239759
2005-10-27

Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitor

#23792
20050239745
2005-10-27

Novel topical ophthalmic formulations

#23793
20050239743
2005-10-27

Compositions and methods to inhibit restenosis

#23794
20050239735
2005-10-27

Enhancement of immune responses

#23795
20050239722
2005-10-27

Composition for the treatment of ear infections and method

#23796
20050239720
2005-10-27

Combination of an agent that attenuates topoisomerase 1 activity and an agent that inhibits heat shock protein 90 for use in chemotherapy

#23797
20050239719
2005-10-27

Methods of using and compositions comprising thalidomide for the treatment and management of pulmonary hypertension

#23798
20050239707
2005-10-27

Combined use of derivatives of GLP-1 analogs and PPAR ligands

#23799
20050239703
2005-10-27

Anticancer peptide compositions

#23800
20050239686
2005-10-27

Methods and compositions for optimization of oxygen transport by cell-free systems

#23801
20050239685
2005-10-27

Tissue volume reduction

#23802
20050239167
2005-10-27

Methods of treatment with interferson and albumin fusion protein

#23803
20050239141
2005-10-27

Modified antibody variable domains

#23804
20050238739
2005-10-27

Composition comprising a combination of calcium, cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement

#23805
20050238738
2005-10-27

Methods for deriving, isolating, and/or extracting amino acid compositions from Fenugreek seed

#23806
20050238736
2005-10-27

Natural immunostimulant compositions, methods for obtaining the same and pharmaceutical formulations thereof

#23807
20050238735
2005-10-27

Orals dosage Noni formulations

#23808
20050238733
2005-10-27

Topical anesthesia of the urinary bladder

#23809
20050238731
2005-10-27

Composition and method for treating the effects of diseases and maladies of the upper digestive tract

#23810
20050238729
2005-10-27

Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination

#23811
20050238728
2005-10-27

Synergistic topically applied personal hygiene product

#23812
20050238727
2005-10-27

Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer

#23813
20050238715
2005-10-27

Developing a delivery system for multi-pharmaceutical active materials at various release rates

#23814
20050238710
2005-10-27

Vitamin replacement as a hangover ameliorative

#23815
20050238707
2005-10-27

Method of cancer treatment

#23816
20050238702
2005-10-27

Medical composition containing photocrosslinkable chitosan derivative

#23817
20050238693
2005-10-27

Process for the preparation and activation of susbstances and a means of producing same

#23818
20050238675
2005-10-27

Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications

#23819
20050238672
2005-10-27

Antifungal drug delivery

#23820
20050238666
2005-10-27

Methods of enhancing stem cell engraftment

#23821
20050238660
2005-10-27

Cpg formulations and related methods

#23822
20050238654
2005-10-27

Compositions and methods for weight loss

#23823
20050238648
2005-10-27

Composition and method for trating inflammatory disorders

#23824
20050238645
2005-10-27

Method and composition for altering a B cell mediated pathology

#23825
20050238640
2005-10-27

Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs

#23826
20050238638
2005-10-27

Dietary Supplement that Serves as a Carbohydrate Blocker and Hangover Remedy

#23827
20050238636
2005-10-27

Food supplement formulation

#23828
20050238635
2005-10-27

Use of hyrogen peroxide producting enzyme for treatment of otitis media

#23829
20050238634
2005-10-27

Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents

#23830
20050238630
2005-10-27

Compositions and methods for inhibiting pathogenic growth

#23831
20050238622
2005-10-27

Compositions and methods for treating cancer with an oncolytic viral agent

#23832
20050238620
2005-10-27

Methods of suppressing fibrosis and fibrocyte formation

#23833
20050235374
2005-10-20

Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

#23834
20050234248
2005-10-20

Method of producing preparations rich in tocotrienol

#23835
20050234134
2005-10-20

Betamimetics with a prolonged duration of activity, processes for preparing them, and their use as pharmaceutical compositions

#23836
20050234124
2005-10-20

Carboxyalkylether-ACAT inhibitor combinations

#23837
20050234122
2005-10-20

Prevention of and countermeasures against viral infection

#23838
20050234089
2005-10-20

Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident

#23839
20050234068
2005-10-20

Composition and method of decreasing renal ischemic damage

#23840
20050234060
2005-10-20

Pyrrolotriazine kinase inhibitors

#23841
20050234043
2005-10-20

ACE inhibitor-vasopressin antagonist combinations

#23842
20050234028
2005-10-20

Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation

#23843
20050234025
2005-10-20

Compositions comprising one or more policosanols and/or policosanoic acids combined with sterol and/or steroid based ascorbic acid derivatives, and uses thereof

#23844
20050234024
2005-10-20

Materials and methods for the treatment of ulcerative colitis

#23845
20050234019
2005-10-20

Arginine silicate inositol complex and use thereof

#23846
20050234013
2005-10-20

Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

#23847
20050234012
2005-10-20

Combinations of viscoelastics for use during surgery

#23848
20050234011
2005-10-20

Re-epithelializing pharmaceutical compositions comprising xanthan gum

#23849
20050234009
2005-10-20

Method of treating solid tumors and leukemias using combination therapy of vitamin D and anti-metabolic nucleoside analogs

#23850
20050233992
2005-10-20

Method of inhibiting collagen formation by VDUP1 inhibition

#23851
20050233989
2005-10-20

Flavin N-oxides: new anti-cancer agents and pathogen eradication agents

#23852
20050233974
2005-10-20

Treating infectious diseases using ice inhibitors

#23853
20050233967
2005-10-20

Compositions, systems, and methods for focusing a cell-mediated immune response

#23854
20050233966
2005-10-20

Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

#23855
20050233954
2005-10-20

Use of resistin to treat hematopoietic disorders

#23856
20050233950
2005-10-20

Synergistic antimicrobial compositions and methods for reducing biofilm formation

#23857
20050233947
2005-10-20

Combinations of chromium or vanadium with antidiabetics

#23858
20050233946
2005-10-20

Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders

#23859
20050233944
2005-10-20

Arginine compositions for coordinate modification of multiple cardiovascular risk factors

#23860
20050233942
2005-10-20

Oxygenated dibenzo-alpha-pyrone chromoproteins

#23861
20050233402
2005-10-20

Heparinase III HLGAG fragments and uses thereof

#23862
20050233014
2005-10-20

Methods for affecting homeostasis and metabolism in a mammalian body

#23863
20050233013
2005-10-20

Methods for enhancing the transport of glucose for balancing blood sugar levels

#23864
20050233010
2005-10-20

Lithium combinations, and uses related thereto

#23865
20050233008
2005-10-20

Comprehensive pharmacologic therapy for treatment of a dysfunction

#23866
20050233005
2005-10-20

Use of glycosaminoglycans and zinc derivatives for insect bites, stings and the like

#23867
20050233004
2005-10-20

Composition of Chinese drugs having neuro-protecting activity

#23868
20050233001
2005-10-20

Nanoparticulate megestrol formulations

#23869
20050232993
2005-10-20

Dosage form containing promethazine and another drug

#23870
20050232987
2005-10-20

Dosage form containing a morphine derivative and another drug

#23871
20050232986
2005-10-20

Dosage form containing promethazine and another drug

#23872
20050232981
2005-10-20

Compositions capable of facilitating penetration across a biological barrier

#23873
20050232980
2005-10-20

Transdermal chondroitin and glucosamine delivery system and method of use

#23874
20050232925
2005-10-20

Protease activity of thrombin inhibits angiogenesis

#23875
20050232923
2005-10-20

Methods and compositions for treating MCP-1 related pathologies

#23876
20050232908
2005-10-20

Method of preparing a pharmaceutical composition comprising fermented ginseng

#23877
20050232907
2005-10-20

Use of herpes vectors for tumor therapy

#23878
20050232902
2005-10-20

Injectable bioartificial tissue matrix

#23879
20050232901
2005-10-20

Materials and methods for treating or preventing oxalate-related disease

#23880
20050232896
2005-10-20

Cd137 as a proliferation factor for hematopoietic stem cells

#23881
20050232895
2005-10-20

Anti-viral pharmaceutical compositions

#23882
20050232874
2005-10-20

Compound and method of treatment for fungal pathologies of the oral cavity

#23883
20050232873
2005-10-20

Aerosol formulation containing particulate formoterol, propellant and polar cosolvent

#23884
20050232871
2005-10-20

Use of compounds in a dry powder inhaler

#23885
20050232868
2005-10-20

Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions

#23886
20050232862
2005-10-20

Combination therapy for the treatment of estrogen-sensitive drugs

#23887
20050231646
2005-10-20

Circuit for processing video signal including information such as caption

#23888
20050228053
2005-10-13

Combination therapy for the treatment of estrogen-sensitive disease

#23889
20050228051
2005-10-13

Immunoregulatory compounds and derivatives and methods of treating diseases therewith

#23890
20050228044
2005-10-13

PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders

#23891
20050228032
2005-10-13

Antimicrobial compositions

#23892
20050228001
2005-10-13

Methods and compositions for treating platelet-related disorders

#23893
20050227979
2005-10-13

Non-imidazole aryloxypiperidines

#23894
20050227952
2005-10-13

Extended cycle multiphasic oral contraceptive method

#23895
20050227951
2005-10-13

Verification of translation

#23896
20050227949
2005-10-13

Compositions and methods for treatment of viral and bacterial infections

#23897
20050227944
2005-10-13

Method of treating using methyl-beta-cyclodextrin

#23898
20050227932
2005-10-13

Combinational therapy involving a small molecule inhibitor of the MDM2: p53 interaction

#23899
20050227930
2005-10-13

Cholesterol lowering combination

#23900
20050227929
2005-10-13

Combination therapy comprising a Cox-2 inhibitor and an antineoplastic agent

#23901
20050227927
2005-10-13

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis

#23902
20050226949
2005-10-13

Medical composition for managing hormone balance

#23903
20050226948
2005-10-13

Methods for enhancing the transport of glucose into muscle

#23904
20050226946
2005-10-13

Composition obtained from barley shochu stillage and having effects of inhibiting the onset of alcoholic liver injury and healing it as well as favorable taste, and processing for producing the same

#23905
20050226945
2005-10-13

Compositions and methods for the treatment of radiation burns and other traumatic skin conditions

#23906
20050226942
2005-10-13

Compositions for alleviating inflammation and oxidative stress in a mammal

#23907
20050226940
2005-10-13

Antitumour compositions containing taxane derivatives

#23908
20050226928
2005-10-13

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

#23909
20050226908
2005-10-13

Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use

#23910
20050226907
2005-10-13

Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens

#23911
20050226906
2005-10-13

Nutrient system for individualized responsive dosing regimens

#23912
20050226898
2005-10-13

Compositions and methods for transdermal oxybutynin therapy

#23913
20050226897
2005-10-13

Method of protecting against coccidiosis

#23914
20050226880
2005-10-13

Use of a preparation based on an antibody directed against a tumor-associated glycosylation

#23915
20050226871
2005-10-13

Compositions and methods for promoting nerve regeneration

#23916
20050226858
2005-10-13

Compositions containing reduced coenzyme Q10 and carotenoid

#23917
20050226857
2005-10-13

T cell therapy for the treatment of cachexia and chronic diseases

#23918
20050226854
2005-10-13

Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts

#23919
20050226846
2005-10-13

Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression

#23920
20050226830
2005-10-13

Nano pearl cream

#23921
20050222273
2005-10-06

Treatment of female sexual dysfunction

#23922
20050222270
2005-10-06

Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis

#23923
20050222263
2005-10-06

Compositions against stress-related diseases and methods for treating stress-related diseases

#23924
20050222262
2005-10-06

Novel NIDDM regimen

#23925
20050222259
2005-10-06

Methods of activating PPAR-alpha nuclear receptors in mammals

#23926
20050222253
2005-10-06

Anti-cancer nitro- and thia-fatty acids

#23927
20050222250
2005-10-06

Curcumin for the prevention and/or treatment of tissue damage

#23928
20050222249
2005-10-06

Softgel of NLKJ for treating prostate diseases

#23929
20050222232
2005-10-06

Compositions and methods for treating hair loss using non-naturally occurring prostaglandins

#23930
20050222195
2005-10-06

Anti-constipation composition

#23931
20050222165
2005-10-06

Pharmaceutical combinations

#23932
20050222163
2005-10-06

Combinations of signal transduction inhibitors

#23933
20050222137
2005-10-06

Combination of organic compounds

#23934
20050222136
2005-10-06

Active substance combination

#23935
20050222135
2005-10-06

Active substance combination

#23936
20050222122
2005-10-06

Statin therapy for enhancing cognitive maintenance

#23937
20050222114
2005-10-06

Use of new etonogestrel esters

#23938
20050222103
2005-10-06

Airway alkalinization as therapy for airway diseases

#23939
20050222102
2005-10-06

Treatment of rhinitis with anticholinergics alone or in combination with antihistamines, phosphodiesterase 4 inhibitors, or corticosteroids

#23940
20050222101
2005-10-06

Method and composition for treatment of skin conditions

#23941
20050222100
2005-10-06

Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm

#23942
20050222095
2005-10-06

Anti-bacterial plant compositions

#23943
20050222094
2005-10-06

Treatment of inflammatory bowel disease

#23944
20050222092
2005-10-06

Use of s1p receptor agonists in heart diseases

#23945
20050222079
2005-10-06

Preparation containing folic acid, vitamin b6, and vitamin b12, and use thereof

#23946
20050222076
2005-10-06

Nucleic acid based composition for cell proliferation

#23947
20050222060
2005-10-06

Compositions and methods to initiate or enhance antibody and major-histocompatibility class I or class II-restricted t cell responses by using immunomodulatory, non-coding rna motifs

#23948
20050222054
2005-10-06

Combination comprising a CDK inhibitor and doxorubicin

#23949
20050222050
2005-10-06

Compositions and methods for reducing or preventing obesity

#23950
20050222049
2005-10-06

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis

#23951
20050222046
2005-10-06

Pharmaceutical preparations of glutathione and methods of administration thereof

#23952
20050222016
2005-10-06

Nucleoside analogs in combination therapy of herpes simplex infections

#23953
20050222014
2005-10-06

Multiple agent therapy for sexual dysfunction

#23954
20050222013
2005-10-06

Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy

#23955
20050222010
2005-10-06

Composition for treating or preventing hyperuricemia

#23956
20050220912
2005-10-06

Anti-inflammatory composition for treating pelvic endometriosis

#23957
20050220911
2005-10-06

Anti-allergic composition and method for denaturing allergen

#23958
20050220909
2005-10-06

Composition for protection against superficial vasodilator flush syndrome

#23959
20050220908
2005-10-06

Anti-inflammatory compositions for multiple sclerosis

#23960
20050220907
2005-10-06

Implanted medical devices with anti-inflammatory coatings

#23961
20050220906
2005-10-06

Pharmaceutical composition for treating rheumatism and the preparation thereof

#23962
20050220905
2005-10-06

Formulations useful in the treatment of male and female impotence

#23963
20050220904
2005-10-06

Pharmaceutical composition for treatment of BPH and preparation thereof

#23964
20050220901
2005-10-06

Methods of pharmaceutical separation from plants

#23965
20050220899
2005-10-06

Use of cisplatin in combination with folic acid for increasing cisplatin efficacy

#23966
20050220897
2005-10-06

Indium supplement compositions and methods therefor

#23967
20050220894
2005-10-06

Colostrum-based composition

#23968
20050220881
2005-10-06

Pharmaceutical composition

#23969
20050220869
2005-10-06

Particulate compositions

#23970
20050220846
2005-10-06

Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function

#23971
20050220810
2005-10-06

Anti-aging preparation

#23972
20050220802
2005-10-06

Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides

#23973
20050220791
2005-10-06

Novel of cytokine inhibitors

#23974
20050220778
2005-10-06

Method for reduction of pathogenic bacteria in an aqueous environment

#23975
20050220773
2005-10-06

Implant containing cells having growhfactor gene transferred thereinto

#23976
20050220768
2005-10-06

Materials and methods for treating ocular-related disorders

#23977
20050220765
2005-10-06

Viruses with enhanced lytic potency

#23978
20050220763
2005-10-06

Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma

#23979
20050220761
2005-10-06

Use of il6r/il6 chimera in nerve cell regeneration

#23980
20050220754
2005-10-06

Vitamin directed targeting therapy

#23981
20050220719
2005-10-06

Nasal passage cleaning composition

#23982
20050220718
2005-10-06

Stable pharmaceutical solution formulations for pressurized metered dose inhalers

#23983
20050220715
2005-10-06

Methods and compositions for improving drug safety

#23984
20050220705
2005-10-06

Methods for treating non-melanoma cancers with PABA

#23985
20050215647
2005-09-29

Amine compounds and inhibiting neurotransmitter reuptake

#23986
20050215640
2005-09-29

HMB compositions and uses thereof

#23987
20050215633
2005-09-29

Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means

#23988
20050215629
2005-09-29

PTPase inhibitors and methods of using the same

#23989
20050215625
2005-09-29

Combination therapy for anticoagulation

#23990
20050215624
2005-09-29

Regulation of NAD(P)H oxidase growth and transcription in melanoma cells

#23991
20050215617
2005-09-29

Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction

#23992
20050215604
2005-09-29

Combination therapies with epothilones and carboplatin

#23993
20050215583
2005-09-29

Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid

#23994
20050215571
2005-09-29

Therapeutic combination for cognititon enhancement and psychotic disorders

#23995
20050215565
2005-09-29

Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents

#23996
20050215564
2005-09-29

Methods and compositions for treating hyperproliferative conditions

#23997
20050215552
2005-09-29

Method for treating obesity

#23998
20050215545
2005-09-29

Methods of treating HIV infection

#23999
20050215544
2005-09-29

Methods of treating HIV infection

#24000
20050215543
2005-09-29

Methods of treating HIV infection